Anika Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Anika Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Anika Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 28, 2024 was 14.6M shares, a 0.03% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 14.6M +4.71K +0.03% Oct 28, 2024 10-Q 2024-11-04
Q2 2024 14.8M +166K +1.13% Jul 29, 2024 10-Q 2024-08-08
Q1 2024 14.8M +196K +1.34% Apr 22, 2024 10-K/A 2024-04-26
Q3 2023 14.6M +31.2K +0.21% Oct 26, 2023 10-Q 2023-11-03
Q2 2023 14.6M +31.2K +0.21% Jul 31, 2023 10-Q 2023-08-08
Q1 2023 14.6M +89.1K +0.61% Mar 8, 2023 10-K 2023-03-16
Q3 2022 14.6M +173K +1.2% Oct 31, 2022 10-Q 2022-11-09
Q2 2022 14.6M +177K +1.23% Jul 29, 2022 10-Q 2022-08-04
Q1 2022 14.5M +177K +1.23% Apr 28, 2022 10-Q 2022-05-06
Q3 2021 14.4M +222K +1.56% Oct 25, 2021 10-Q 2021-11-05
Q2 2021 14.4M +216K +1.52% Jul 26, 2021 10-Q 2021-08-06
Q1 2021 14.4M +199K +1.4% Apr 20, 2021 10-K/A 2021-04-26
Q3 2020 14.2M -54.9K -0.38% Oct 26, 2020 10-Q 2020-11-05
Q2 2020 14.2M +424K +3.08% Jul 27, 2020 10-Q 2020-08-07
Q1 2020 14.2M -38.8K -0.27% Feb 24, 2020 10-K 2020-03-06
Q3 2019 14.3M +57.9K +0.41% Oct 17, 2019 10-Q 2019-10-28
Q2 2019 13.8M -801K -5.49% Jul 18, 2019 10-Q 2019-07-26
Q1 2019 14.2M -538K -3.65% Apr 22, 2019 10-Q 2019-05-06
Q4 2018 14.2M -482K -3.28% Feb 10, 2019 10-K 2019-02-27
Q3 2018 14.2M -450K -3.07% Oct 18, 2018 10-Q 2018-10-26
Q2 2018 14.6M -74.8K -0.51% Jul 25, 2018 10-Q 2018-07-31
Q1 2018 14.7M +90.6K +0.62% May 3, 2018 10-Q 2018-05-10
Q4 2017 14.7M Feb 9, 2018 10-K 2018-02-27
Q3 2017 14.7M +38.5K +0.26% Oct 17, 2017 10-Q 2017-10-27
Q2 2017 14.7M -119K -0.81% Jul 20, 2017 10-Q 2017-07-28
Q1 2017 14.7M +324K +2.26% Apr 27, 2017 10-Q 2017-05-04
Q3 2016 14.6M -14.4K -0.1% Oct 26, 2016 10-Q 2016-11-01
Q2 2016 14.8M +146K +1% Jul 28, 2016 10-Q 2016-08-01
Q1 2016 14.3M -216K -1.49% Mar 4, 2016 10-K 2016-03-10
Q3 2015 14.6M +134K +0.92% Oct 29, 2015 10-Q 2015-11-03
Q2 2015 14.6M +146K +1.01% Jul 31, 2015 10-Q 2015-08-04
Q1 2015 14.5M +221K +1.55% Mar 9, 2015 10-K 2015-03-13
Q3 2014 14.5M +678K +4.91% Oct 31, 2014 10-Q 2014-11-06
Q2 2014 14.5M +824K +6.03% Aug 1, 2014 10-Q 2014-08-04
Q1 2014 14.3M +406K +2.92% Mar 10, 2014 10-K 2014-03-13
Q3 2013 13.8M +12.8K +0.09% Oct 31, 2013 10-Q 2013-11-05
Q2 2013 13.7M -140K -1.02% Aug 1, 2013 10-Q 2013-08-06
Q1 2013 13.9M +250K +1.83% Mar 8, 2013 10-K 2013-03-14
Q3 2012 13.8M +188K +1.38% Nov 1, 2012 10-Q 2012-11-08
Q2 2012 13.8M +181K +1.33% Aug 3, 2012 10-Q 2012-08-07
Q1 2012 13.7M Mar 9, 2012 10-K 2012-03-13
Q3 2011 13.6M Nov 1, 2011 10-Q 2011-11-04
Q2 2011 13.6M Aug 3, 2011 10-Q/A 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.